ReviewJournal of experimental orthopaedics2025
Elevated risk of patellofemoral osteoarthritis following ACL reconstruction compared to contralateral knees: A systematic review and meta-analysis.
Review in Journal of experimental orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Early Patellofemoral Osteoarthritis Following ACL Reconstruction: A Narrative Review.Healthcare (Basel, Switzerland) · 2026Review
- Structural severity versus clinical reality: Are we measuring the right endpoints?Journal of experimental orthopaedics · 2026Article
- Elevated risk of patellofemoral osteoarthritis following ACL reconstruction compared to contralateral knees: A systematic review and meta-analysis.Journal of experimental orthopaedics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the development of patellofemoral osteoarthritis (PFOA) in the affected knee of anterior cruciate reconstruction (ACL-R) patients compared to their contralateral knee. The impact of graft choice on PFOA progression was also examined. Methods: A systematic literature search was performed up to 1 June 2025. Studies at level of evidence II and III reporting imaging outcomes of the patellofemoral (PF) joint following ACL-R and contralateral knees were included. Studies involving isolated primary ACL-R procedures, regardless of meniscus status, were considered. The meta-analysis was performed to assess if ACL-R was associated with a higher likelihood of PFOA compared to contralateral knees. Furthermore, a sub-analysis was conducted to evaluate whether the patellar tendon autograft was associated with a higher chance of PFOA than hamstring autografts. The random effects model was used to calculate the pooled odds ratio of PFOA in patients following ACL-R compared to the control group. Meta-regression analysis was performed to determine whether sample size, follow-up duration and population age significantly influenced the odds ratio. Results: Eleven studies met the inclusion criteria and were included in this review. A total of 1206 participants were included, with an average male/female ratio of 57/49 and a pooled weighted mean age of 27 years. The follow-up duration varied from 1 to 17.8 years, with an average of 5 years. Radiographic definitions of PFOA were determined using the Kellgren-Lawrence and the Osteoarthritis Research Society International (OARSI) classifications, while the magnetic resonance imaging (MRI) PFOA definition was derived from the MRI Osteoarthritis Knee Score (MOAKS) grading. Patients undergoing ACL-R demonstrated a significantly higher likelihood of PFOA compared to their contralateral knees ( Conclusions: Patients undergoing ACL-R are more likely to develop PFOA than their contralateral knees. No significant difference in risk of PFOA development was found between hamstrings tendon and patellar tendon autografts. Level of Evidence: Level II and III, systematic review and meta-analysis studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.